The leading Canadian contender in the race to produce a COVID-19 vaccine is using a breakthrough approach: plants. Quebec-based Medicago will be starting phase three of its trials later this month - but as Emanuela Campanella reports - if it’s approved, the bulk of its doses won’t initially come from Canada.